Coronavirus (COVID-19) Update
Fall classes are offered remotely—either live-online with an instructor, entirely self-paced, or in a blended online format. Please check our coronavirus update page for our latest announcements.
Drug Safety and Adverse Events Reporting
Regulators, the public, and the medical community are scrutinizing the safety profiles of pharmaceuticals more closely than ever. Thus acquiring, verifying and reporting quality safety data are crucial to obtaining and maintaining product approval. This course introduces fundamental concepts essential to drug safety and adverse event reporting and how to apply them to situations encountered during clinical trials and post-marketing reporting. You'll learn why safety reporting is crucial; the definitions of an adverse event and the key reporting issues of seriousness, expectedness, and relationship to the study drug. The course includes a brief overview of reporting requirements in the U.S. and abroad and the documents associated with these reports. The content is appropriate for CRAs, CRCs, drug safety associates, and regulatory affairs personnel.
Professional Credit: CA BRN/LVN Credit--Provider #CEP13114.
Sections Open for Enrollment:
|Date:||Start Time:||End Time:||Meeting Type:||Location:|
|Sat, 12-05-2020||8:30 a.m.||5:00 p.m.||Live-Online||ONLINE|
|Sat, 12-12-2020||8:30 a.m.||5:00 p.m.||Live-Online||ONLINE|
Ask us any questions you may have about this course.